You have been on a compounded GLP-1 for a year. The weight stopped moving at a high dose, the side effects got a form letter and the next email offered a higher dose. Now you are comparing the two programs that prescribe branded medication with a clinician attached. The search keeps returning the same number. GoodLife Health vs Form Health is a comparison between two memberships that both cost $299 a month for a self-pay patient. The fee is the same. What sits inside the fee is where the two part company.
The short answer first. Form Health's $299 a month self-pay plan covers its clinician visits, dietitian appointments, unlimited messaging and its app. Its own FAQ says lab work and medication are billed on top. GoodLife Health's $299 a month covers the clinician, four cardiometabolic lab panels a year and the visits and messaging between them, with medication prescribed to your own pharmacy at that pharmacy's price. Form Health also accepts insurance and Medicare, according to its own FAQ. GoodLife Health does not bill insurance at all. The rest of this piece sets out both sides for year one, with the dates of every price used. It says plainly who should choose which.
- Both programs charge $299 a month for a self-pay patient and both prescribe only FDA-approved medication.
- Form Health bills lab work and medication separately and accepts most major insurers and Medicare.
- GoodLife Health includes four cardiometabolic lab panels a year in the fee and sends prescriptions to your pharmacy at its own price.
- Year one is $3,588 in membership on either side. Medication comes on top. Wegovy pens at the manufacturer's $349 standard self-pay price of September 2026 come to $4,188 a year.
- If your insurance covers obesity care and you want a dietitian-led weight program, Form Health's insurance route may cost you less.
Two programs, one price, two different fees
A price is a number. A fee is a list of what the number buys. The reason this comparison is worth reading to the end is that the price is identical and the lists are not.
Form Health describes itself as a medical weight loss program. Its care team is physician-led, with obesity medicine clinicians, endocrinologists, registered dietitians and advanced practice providers. The program is built around frequent video visits and messaging through its app. That is a serious clinical model and it is a weight program by design. GoodLife Health is a cardiometabolic optimization membership. Weight is one of the things it treats, alongside insulin resistance, lipids, thyroid and hormones, because in the clinic those problems arrive together and a clinician who only sees one of them misses the others. The definitive guide to cardiometabolic optimization explains the model in full.
That difference in scope explains the difference in the fee. A weight program needs a scale, a visit and a prescription. A cardiometabolic membership needs the labs, because the labs are how the clinician finds out why the weight stopped moving. So one program bills labs on top and the other builds them in.
What Form Health publishes about its own plan
Everything in this section comes from Form Health's own FAQ, read in November 2026. We say nothing about another company that it does not say about itself.
Form Health offers two ways to pay. The first is insurance. Its FAQ states that care team visits, lab tests and medication costs are covered by most major private insurers and by Medicare. The patient pays any copay or deductible as they would for an in-person visit. The second is a self-pay plan at $299 a month, which covers Form clinician visits, registered dietitian appointments, unlimited messaging and access to the Form platform. On that plan, in the FAQ's words, you are responsible for the cost of any lab work and medications. The self-pay fee is described as HSA and FSA eligible. The program prescribes only FDA-approved medications and names Wegovy, Zepbound, Saxenda and Contrave among them. Membership can be cancelled at any time.
Read that list again as a self-pay patient, because it is the honest version of what you would be buying. The $299 buys the people and the app. The blood work that tells those people what is happening in your body is a separate bill, at a price the FAQ does not state. The medication is another. For a patient whose insurance covers obesity care, the insurance route may be the better deal of the two programs described here. This piece says so again at the end.
The price is identical. The list of what it buys is not. The list is the whole decision.
What the GoodLife Health fee buys and what it does not
The membership is $299 a month, month to month. At sign-up, $598 is held on your card to cover the first two months. It is a hold. It is charged only once a clinician reviews your intake and accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. After that the membership runs month to month.
The fee covers clinicians licensed in all fifty states. It covers four cardiometabolic lab panels a year, drawn at any Quest patient service center, with every result in your hands. It covers the video visits and the asynchronous messaging with the care team between them. The fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge.
Medication is unbundled. When it is clinically indicated, the clinician prescribes branded, FDA-approved medication to the pharmacy you choose. That pharmacy bills you at its own price. GoodLife Health sets nothing, sees nothing and takes nothing on the medication. Wegovy, Zepbound, Mounjaro and Ozempic are the GLP-1 options. Compounded GLP-1 is never prescribed. Neither are research peptides. The compounded versus branded comparison sets out what changed in 2025 and why the membership holds that line.
On insurance, the position is plain. The membership does not bill insurance and it does not replace it. You keep your plan for the specialist, the scan and the hospital. Whether your plan covers a medication is between you, the plan and the pharmacy. Prior authorization is the pharmacy's process. Nothing about coverage is promised. On HSA and FSA funds, we do not promise the membership fee is eligible. Your account administrator decides, so check with them before using those funds.
A plateau on a GLP-1 is information. Before a dose goes up, a clinician wants Fasting Insulin, Hemoglobin A1c (HbA1c), Lipid Panel, Standard, Apolipoprotein B (ApoB) and TSH With Reflex To Free T4, read against the last draw. Those are among the nine biomarkers inside the fee, drawn every quarter, so the decision to escalate is made on numbers.


Year one, priced on both sides, with the dates
Here is the arithmetic, using only published prices and their dates. Both self-pay fees are $299 a month, so both memberships are $3,588 for year one. On the GoodLife Health side, the four lab panels are inside that figure. On the Form Health side, lab work is billed separately and its FAQ does not publish a price for it, so the table leaves that line as a separate bill of unknown size.
On the GoodLife Health side, medication is prescribed to your pharmacy and billed by it at its own price. At the manufacturers' own self-pay prices published in September 2026, Wegovy pens through NovoCare are $349 a month after an introductory $199 a month for the first two fills, an offer for new patients that runs through December 2026. The Wegovy pill starts at $149 a month at lower doses. Zepbound vials through LillyDirect are $299 to $449 a month depending on dose. A year of Wegovy pens at the $349 standard price is $4,188. A new patient who gets the introductory price for the first two fills pays $3,888. GoodLife Health takes nothing on that figure and its fee does not change when the dose does. The manufacturers' self-pay prices are public and do not depend on which program writes the prescription, so the Wegovy line in the table is the same on both sides. On the Form Health side, the FAQ says medication is billed separately and publishes no price of its own.
Year one: GoodLife Health against Form Health self-pay
Prices as published in September and November 2026. The Wegovy line is the manufacturer's own published price and does not depend on which program prescribes
| Line | GoodLife Health | Form Health self-pay |
|---|---|---|
| Membership, twelve months | $3,588 | $3,588 |
| Lab work | Four cardiometabolic panels a year, inside the fee | Billed separately, price not published |
| Medication | Prescribed to your pharmacy at its price, nothing taken on it | Billed separately, FDA-approved only |
| Example, Wegovy pens at NovoCare's $349 standard self-pay price, September 2026, whoever prescribes | $4,188 a year | $4,188 a year |
| Insurance | Not billed. Pairs with your plan for catastrophic cover | Accepted for visits, labs and medication, with copays and deductible |
| Scope of care | Cardiometabolic, hormones, thyroid and weight | Medical weight loss with a dietitian |
| Commitment | $598 held for the first two months, charged only on acceptance, month to month after | Cancel at any time |
The table says what the opening said. On the fee, the two programs are level. On what the fee buys, the GoodLife Health side carries the labs and the Form Health side carries a dietitian and an insurance route. A self-pay patient who wants the labs is paying for them either way. On one side they are already in the number.
The insurance question, answered straight
Form Health publishes an insurance route and it deserves a straight answer here. Suppose your plan covers obesity medicine visits and the medication. Suppose you are also comfortable in a weight-focused program with a dietitian. Then the insurance route at Form Health may cost you less in year one than any self-pay membership, including this one. That is how insurance works when it works.
The difficulty is that for many patients it does not work. The Kaiser Family Foundation's health tracking poll of late 2025 is one published source on what GLP-1 users pay and how affordable they find it. Those are the patients the self-pay plans exist for on both sides. For them the comparison in the table above is the real one. The true monthly cost of GLP-1 telehealth walks through the full-year arithmetic for a self-pay patient in more detail.
There is one more group the insurance route does not serve. It is the reader this piece was written for. If you arrived here from a compounded program, the question is no longer which pharmacy fills the prescription. The question is why a medication that worked for eight months stopped working and whether the next step should be a higher dose or a different diagnosis. That question is answered with labs, read by the clinician who will prescribe, every quarter. It is the thing the GoodLife Health fee was built around.
What you can do this week, whether or not you join
Three things, none of which require a membership. First, write down the dose you are on and the date of each increase, because any clinician who takes you on will ask for it and the compounded product's label is the only record you have. Second, ask whoever prescribed it for your most recent fasting insulin, lipid panel and thyroid result. If the answer is that none were drawn, you have learned something about the program you are leaving. Third, if you intend to use insurance, call your plan and ask whether obesity medicine visits are covered and whether Wegovy or Zepbound is on the formulary with or without prior authorization. The answers decide which of the two programs in this piece is cheaper for you. They are quick questions to ask.
Who this is not for
This membership is not for the patient whose insurance covers obesity care and who wants a dietitian-led weight program. Form Health's insurance route serves that person. It is the better-priced option for them. It is not for the patient who wants the lowest possible monthly number for a prescription and nothing else. A $99 app exists for that purpose and this membership will not compete with it on price. The piece on whether a $99 app is the same thing explains the difference without pretending the price gap is not real. It is not for anyone who wants compounded GLP-1 or research peptides, because neither is ever prescribed here. And it is not for the patient who is already being worked up properly, with quarterly labs read by the clinician who prescribes. If you have that, keep it.
For everyone else, here is the offer in one paragraph. The membership is $299 a month, month to month. At sign-up, $598 is held for the first two months and charged only once a clinician accepts you. If they cannot, the hold is released and you are never charged. Once they do, the first two months are non-refundable. The fee buys a clinician who stays, four cardiometabolic lab panels a year and the visits and messages between them. Medication is prescribed to your own pharmacy at that pharmacy's price with nothing taken on it. It returns the diagnosis an eight-minute visit never produced and the markers followed over time. It is different because it tests first and treats second. It sells neither the drug nor the dose. If you are on a plateau at a high dose with nobody looking at why, that is the reason to start now, before the next escalation email arrives.
Related Reading
- Cardiometabolic optimization: the definitive guide
- How much does a direct primary care membership cost?
- Compounded vs branded GLP-1: what changed in 2025
- The true monthly cost of GLP-1 telehealth
- Branded GLP-1 pass-through prices
References
- Frequently Asked Questions — Form Health. 2026. www.formhealth.co/faq
- Form Health — physician-led medical weight loss (homepage). 2026. www.formhealth.co/
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
- KFF Health Tracking Poll: prescription drug costs and GLP-1 use — Kaiser Family Foundation. 2025. www.kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/